Cognitive–behavioral therapy: what benefits can it offer people with multiple sclerosis?

References

• Goodkin D. Interferon β therapy for multiple sclerosis. Lancet352, 1486–1487 (1998).
   PubMed Web of Science ®Google Scholar
• Goodin DS. Disease-modifying therapy in multiple sclerosis: update and clinical implications. Neurology71(24 Suppl. 3), 8–13 (2008).
   PubMed Web of Science ®Google Scholar
• Rudick RA. Disease-modifying drugs for relapsing–remitting multiple sclerosis and future directions for multiple sclerosis therapeutics. Arch. Neurol.56(9), 1079–1084 (1999).
   PubMed Web of Science ®Google Scholar
• Beck AT. Cognitive therapy and the emotional disorders (Penguin Psychology). Penguin Books, London, UK (1976).
   Google Scholar
• Morley S, Eccleston C, Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain80(1–2), 1–13 (1999).
   PubMed Web of Science ®Google Scholar
• Malouff JM, Thorsteinsson EB, Rooke SE, Bhullar N, Schutte NS. Efficacy of cognitive behavioral therapy for chronic fatigue syndrome: a meta-analysis. Clin. Psychol. Rev.28(5), 736–745 (2008).
   PubMed Web of Science ®Google Scholar
• Moorey S, Cort E, Kapari M et al. A cluster randomized controlled trial of cognitive behaviour therapy for common mental disorders in patients with advanced cancer. Psychol. Med.39(05), 713–723 (2008).
   PubMed Web of Science ®Google Scholar
• Beck A. Cognitive therapy: a 30-year retrospective. Am. Psychol.46, 368–375 (1991).
   PubMed Web of Science ®Google Scholar
• Malcomson KS, Dunwoody L, Lowe-Strong AS. Psychosocial interventions in people with multiple sclerosis: a review. J. Neurol.254, 1–13 (2007).
   PubMed Web of Science ®Google Scholar
• Thomas PW, Thomas S, Hiller C, Galvin K, Baker R. Psychological interventions for multiple sclerosis. Cochrane Database Syst. Rev.1, CD004431 (2006).
   PubMed Web of Science ®Google Scholar
• Janssens AC, van Doorn P, de Boer JB, van der Meche FG, Passchier J, Hintzen RQ. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol. Scand.108(6), 389–395 (2003).
   PubMed Web of Science ®Google Scholar
• Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J. Neurol. Neurosurg. Psychiatry76(4), 469–475 (2005).
   PubMed Web of Science ®Google Scholar
• Dennison L, Moss-Morris R, Chalder T. A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin. Psychol. Rev.29, 141–153 (2009).
   PubMed Web of Science ®Google Scholar
• Mohr D, Boudewyn A, Goodkin D, Bostrom A, Epstein L. Comparative outcomes for individual cognitive–behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J. Consult. Clin. Psychol.69(6), 942–949 (2001).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Likosky W, Bertagnolli A et al. Telephone-administered cognitive–behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J. Consult. Clin. Psychol.68(2), 356–361 (2000).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Hart SL, Julian L et al. Telephone-administered psychotherapy for depression. Arch. Gen. Psychiatry62(9), 1007–1014 (2005).
   PubMed Web of Science ®Google Scholar
• Hind D, O’Cathain A, Cooper C et al. The acceptability of computerised cognitive behavioural therapy for the treatment of depression in people with choric physical disease: a qualitative study of people with multiple sclerosis. Psychol. Health24(1), 1–14 (2009).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Cox D. Multiple sclerosis: empirical literature for the clinical health psychologist. J. Clin. Psychology57(4), 479–499 (2001).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Boudewyn AC, Likosky W, Levine E, Goodkin DE. Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and infection anxiety on adherence and ability to self-inject. Ann. Behav. Med.23(2), 125–132 (2001).
   PubMed Web of Science ®Google Scholar
• Cox D, Mohr DC, Epstein L. Treating self-injection phobia in patients prescribed injectable medications: a case example illustrating a six-session treatment model. Cogn. Behav. Pract.11(3), 278–283 (2004).
   Web of Science ®Google Scholar
• Mohr D, Cox D, Epstein L, Boudewyn A. Teaching patients to self-inject: pilot study of a treatment for injection anxiety and phobia in multiple sclerosis patients prescribed injectable medications. J. Behav. Ther. Exp. Psychiatry33, 39–47 (2002).
   PubMed Web of Science ®Google Scholar
• Mohr D, Cox D, Merluzzi N. Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications. Mult. Scler.11, 182–185 (2005).
   PubMed Web of Science ®Google Scholar
• Hakim EA, Bakheit AMO, Bryant TN et al. The social impact of multiple sclerosis-a study of 305 patients and their relatives. Disabil. Rehabil.22(6), 288–293 (2000).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Dick LP, Russo D et al. The psychosocial impact of multiple scleoris: exploring the patient’s perspective. Health Psychol.18(4), 376–382 (1999).
   PubMed Web of Science ®Google Scholar
• Dennison L, Yardley L, Devereux A, Moss-Morris R. Experiences of adjusting to early stage MS; the patient’s perspective. J. Health Psychol. (2010) (In press).
   PubMedGoogle Scholar
• Moss-Morris R, Dennison L, Yardley L et al. Protocol for the saMS trial (supportive adjustment for multiple sclerosis): a randomized controlled trial comparing cognitive behavioural therapy to supportive listening for adjustment to multiple sclerosis. BMC Neurology9, 45 (2009).
   PubMed Web of Science ®Google Scholar
• van Kessel K, Moss-Morris R. Understanding multiple sclerosis fatigue: a synthesis of biological and psychological factors. J. Psychosom. Res.61(5), 583–585 (2006).
   PubMed Web of Science ®Google Scholar
• Benedict R, Shapiro A, Priore R et al. Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients. Mult. Scler.6, 391–396 (2000).
   PubMed Web of Science ®Google Scholar
• Mohr D, Goodkin D, Likosky W et al. Therapeutic expectations of patients with multiple sclerosis upon initiating interferon β-1b: relationship to adherence to treatment. Mult. Scler.2, 222–226 (1996).
   PubMedGoogle Scholar
• van Kessel K, Moss-Morris R, Willoughby E, Chalder T, Johnson M, Robinson E. A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom. Med.70, 205–213 (2008).
   PubMed Web of Science ®Google Scholar
• Thomas S, Thomas P, Nock A et al. Development and preliminary evaluation of a cognitive behavioural approach to fatigue management in people with multiple sclerosis. Patient Educ. Couns.78, 240–249 (2010).
   PubMed Web of Science ®Google Scholar
• Kern S, Ziemssen T. Review: brain immune communication psychoneuroimmunology of multiple sclerosis. Mult. Scler.14(1), 6–21 (2008).
   PubMed Web of Science ®Google Scholar
• Foley FW, Traugott U, LaRocca NG. A prospective study of depression and immune dysregulation in multiple sclerosis. Arch. Neurol.49(3), 238–244 (1992).
   PubMed Web of Science ®Google Scholar
• Mohr D, Hart S, Julian L, Cox D, Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ328(7442), 731 (2004).
   PubMed Web of Science ®Google Scholar
• Cuijpers P, van Straten A, Andersson G. Internet-administered cognitive behavior therapy for health problems: a systematic review. J. Behav. Med.31(2), 169–177 (2008).
   PubMed Web of Science ®Google Scholar
• Forman AC, Lincoln NB. Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial. Clin. Rehabil.24(3), 211–221 (2010).
   PubMed Web of Science ®Google Scholar
• Bogosian A, Moss-Morris R, Yardley L, Dennison L. Experiences of partners of people in the early stages of multiple sclerosis. Mult. Scler.15(7), 876–884 (2009).
   PubMed Web of Science ®Google Scholar
• Bogosian A, Moss-Morris R, Bishop F, Hadwin J. Psychosocial adjustment in children and adolescents with a parent with multiple sclerosis: a systematic review. Clin. Rehabil. (2010) (In press).
   PubMedGoogle Scholar
• Schwartz L, Kraft GH. The role of spouse responses to disability and family environment in multiple sclerosis. Am. J. Phys. Med. Rehabil.78(6), 525–532 (1999).
   PubMed Web of Science ®Google Scholar
• Hayes SC, Follette VM, Linehan M. Mindfulness and Acceptance: Expanding the Cognitive Behavioural Tradition.The Guilford Press, NY, USA (2004)
   Google Scholar
• McCracken LM, Vowles KE, Eccleston C. Acceptance-based treatment for persons with complex, long standing chronic pain: a preliminary analysis of treatment outcome in comparison to a waiting phase. Behav. Res. Ther.43(10), 1335–1346 (2005).
   PubMed Web of Science ®Google Scholar